Many programs are available from federal and state governments, non-profits, manufacturers, and other organizations to help you get the drugs you need at a reduced cost. Eligibility is often based on income, insurance or Medicare status, and other factors. You’ll need to apply through each program, either online, over the phone, or with your doctor's help. The following program is offered by the manufacturer of this drug.
|Program Name:||Eisai Reimbursement Resources|
|How do I apply?||Go to the program website and call the number provided specific to your medication for more information.|
|What are the benefits?||Contact the program to see how they can financially help you.|
|What are the restrictions?||Most people without insurance and with limited incomes will qualify. You will need a valid prescription and proof of househould income.|
|Keep in mind||N/A|
You may find that filling a 90-day supply will reduce your total cost for this prescription. As an added bonus, you'll make fewer trips to the pharmacy, saving you time and money.
If you have insurance or Medicare, you may find that you receive lower prices if you fill your prescriptions through your plan’s mail order pharmacy. Many insurance plans (and most Medicare plans) are now offering similar rates at a select group of “preferred” retail pharmacies. Some plans may require that you fill through a mail order pharmacy for fills of more than a 30-day supply.
To switch to 90-day fills, note that you'll need a new prescription from your doctor; a 30-day quantity prescription will not allow 90-day fills.
There may be other prescriptions in the same class (that work in the same way) that could treat your condition just as well at a much lower cost.
If you're taking an expensive brand-name-only drug, it may be worth asking your doctor if there are any other less expensive, generic, or over-the-counter options that might work for you.
It is possible that Banzel may become available as generic rufinamide after May 2023. Generics are typically much cheaper than the branded version of a drug.
This is the earliest possible generic release date based on patent expiration at this time. It is possible that rufinamide could become available sooner or later, depending on FDA approval, other patents, and whether any manufacturers decide to make a generic version of Banzel.